Patent Assignment
Reel/Frame 057683/0099
Assignment of Assignor's Interest
Recorded: 2021-09-14
Pages: 37
Assignor
BLUEBIRD BIO, INC.
Executed: 2021-09-07
Assignee
2SEVENTY BIO, INC.
60 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(139)
Mnd Promoter Chimeric Antigen Receptors
Application:
61/984,561 →
Mnd Promoter Chimeric Antigen Receptors
Application:
16/987,768 →
Publication:
US 2021/0032658
Methods for Manufacturing Adoptive Cell Therapies
Application:
61/984,558 →
Improved Methods for Manufacturing Adoptive Cell Therapies
T Cell Compositions
Application:
62/008,957 →
T Cell Compositions
Methods of Making T Cell Compositions
Multipartite Signaling Proteins and Uses Thereof
Application:
61/859,697 →
Multipartite Signaling Proteins and Uses Thereof
Application:
61/934,092 →
Multipartite Signaling Proteins and Uses Thereof
Application:
16/540,673 →
Publication:
US 2020/0071399
Multipartite Signaling Proteins and Uses Thereof
Bcma Chimeric Antigen Receptors
Application:
62/028,664 →
Bcma Chimeric Antigen Receptors
Application:
62/044,103 →
Bcma Chimeric Antigen Receptors
Application:
62/152,575 →
Bcma Chimeric Antigen Receptors
Application:
15/328,278 →
Publication:
US 2017/0226216
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Application:
62/091,419 →
Bcma Chimeric Antigen Receptors
Application:
62/200,505 →
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Genome Edited Immune Effector Cells
Application:
62/307,245 →
Genome Edited Immune Effector Cells
Application:
62/322,604 →
Chimeric Antigen Receptor T Cell Compositions
Application:
62/319,703 →
Chimeric Antigen Receptor T Cell Compositions
Application:
62/322,547 →
Chimeric Antigen Receptor T Cell Compositions
Application:
16/092,146 →
Publication:
US 2019/0161530
Salvage Chimeric Antigen Receptor Systems
Application:
62/322,634 →
Salvage Chimeric Antigen Receptor Systems
Application:
62/356,335 →
Salvage Chimeric Antigen Receptor Systems
Il-10 Receptor Alpha Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/375,751 →
Il-10 Receptor Alpha Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/411,154 →
Il-10 Receptor Alpha Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
16/324,357 →
Publication:
US 2019/0309274
Genome Editing Enhancers
Application:
62/377,357 →
Genome Editing Enhancers
Application:
16/325,013 →
Publication:
US 2019/0169597
TIM3 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/378,622 →
TIM3 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/411,167 →
TIM3 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
16/327,700 →
Publication:
US 2019/0262398
Pd-1 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/385,079 →
Pd-1 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/414,279 →
Pd-1 Homing Endonuclease Variants, Compositions, and Methods of Use
TCRa HOMING ENDONUCLEASE VARIANTS
Application:
62/406,689 →
TCRa HOMING ENDONUCLEASE VARIANTS
Application:
62/414,266 →
TCRa HOMING ENDONUCLEASE VARIANTS
TGFBR2 Endonuclease Variants, Compositions, and Methods of Use
Application:
62/409,163 →
TGFBR2 Endonuclease Variants, Compositions, and Methods of Use
Application:
62/414,260 →
TGFBetaR2 ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
Anti-Bcma Car T Cell Compositions
Application:
62/417,840 →
Anti-Bcma Car T Cell Compositions
Application:
62/514,401 →
Anti-Bcma Car T Cell Compositions
Tgfb Signal Convertor
Application:
62/423,565 →
Tgfb Signal Convertor
Application:
62/467,496 →
TGFBeta SIGNAL CONVERTOR
Vcn Enhancer Compositions and Methods of Using the Same
Application:
62/457,504 →
Vcn Enhancer Compositions and Methods of Using the Same
Application:
16/485,048 →
Publication:
US 2019/0365814
Donor Repair Templates Multiplex Genome Editing
Application:
62/459,203 →
Donor Repair Templates Multiplex Genome Editing
Cblb Endonuclease Variants, Compositions, and Methods of Use
Application:
62/511,194 →
Cblb Endonuclease Variants, Compositions, and Methods of Use
Application:
62/567,417 →
Cblb Endonuclease Variants, Compositions, and Methods of Use
Cblb Endonuclease Variants, Compositions, and Methods of Use
Cblb Endonuclease Variants, Compositions, and Methods of Use
PCSK9 Endonuclease Variants, Compositions, and Methods of Use
Application:
62/568,020 →
PCSK9 Endonuclease Variants, Compositions, and Methods of Use
Application:
62/671,762 →
PCSK9 Endonuclease Variants, Compositions, and Methods of Use
NKG2D Daric Receptors
Application:
62/598,902 →
NKG2D Daric Receptors
Application:
62/730,926 →
NKG2D Daric Receptors
Application:
16/771,027 →
Publication:
US 2021/0236546
Daric Interleukin Receptors
Application:
62/598,923 →
Dimerizing Agent Regulated Immunoreceptor Complexes Comprising Interleukin Receptor Signaling Domains
CTLA4 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
62/608,397 →
CTLA4 Homing Endonuclease Variants, Compositions, and Methods of Use
Application:
16/955,241 →
Publication:
US 2021/0002621
Multivalent Chimeric Antigen Receptor
Application:
62/609,847 →
Multivalent Chimeric Antigen Receptor
Application:
16/956,107 →
Publication:
US 2022/0218745
Anti-Bcma Car Antibodies, Conjugates, and Methods of Use
Application:
62/685,043 →
Anti-Bcma Car Antibodies, Conjugates, and Methods of Use
Application:
62/948,488 →
Anti-Bcma Car Antibodies, Conjugates, and Methods of Use
Adoptive Cellular Therapy
Application:
62/657,388 →
Adoptive Cellular Therapy
CD79A Chimeric Antigen Receptors
Application:
62/685,078 →
CD79A Chimeric Antigen Receptors
CD79B Chimeric Antigen Receptors
Application:
62/685,084 →
CD79B Chimeric Antigen Receptors
Application:
16/973,884 →
Publication:
US 2022/0226374
Methods and Systems for Manufacturing Viral Vectors
Application:
62/795,513 →
Methods and Systems for Manufacturing Viral Vectors
Cell Therapy Vessels
Application:
62/756,816 →
Cell Therapy Vessels
Application:
17/291,323 →
Publication:
US 2022/0002653
Pdcd-1 Homing Endonuclease Variants
Application:
62/777,471 →
Pdcd-1 Homing Endonuclease Variants
Homing Endonuclease Variants
Application:
62/777,476 →
Homing Endonuclease Variants
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/779,882 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
17/311,767 →
Publication:
US 2024/0034768
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/779,889 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/835,658 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
17/311,776 →
Publication:
US 2024/0025963
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/779,971 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/835,659 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/779,953 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/835,662 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Adoptive Cell Therapy
Application:
62/821,419 →
Manufacturing Anti-Bcma Car T Cells
Application:
62/830,004 →
Manufacturing Anti-Bcma Car T Cells
Application:
62/944,485 →
CD33 Targeted Immunotherapies
Application:
62/845,304 →
CD33 Targeted Immunotherapies
Application:
62/898,392 →
Cll-1 Targeted Immunotherapies
Application:
62/845,306 →
CD123 Targeted Immunotherapies
Application:
62/845,307 →
Engineered T Cells
Application:
62/845,311 →
Compositions and Methods for Treating Cancer
Application:
62/861,838 →
Compositions and Methods for Treating Cancer
Application:
62/991,314 →
Cell Culture Medium
Application:
62/925,800 →
Cell Culture Medium
Patent:
12,297,451 →
Application:
17/077,134 →
Dimerizing Agent Regulated Immunoreceptor Complexes
Application:
62/908,082 →
Modified Ccr Polypeptides and Uses Thereof
Application:
63/011,494 →
Methods for Manufacturing Viral Vectors
Application:
63/037,777 →
Frb Antibodies
Application:
63/007,990 →
T Cell Receptors
Application:
63/000,800 →
Bcma Chimeric Antigen Receptors
Application:
63/069,784 →
Compositions and Methods for Site-Directed Mutagenesis
Application:
63/128,391 →
Aml Targeted Immunotherapies
Application:
63/111,255 →
Aml Targeted Immunotherapies
Application:
63/112,023 →
CD33 Targeted Immunotherapies
Application:
63/111,280 →
T Cell Receptors
Application:
63/221,819 →
Mnd Promoter Chimeric Antigen Receptors
Methods of Making T Cell Compositions
Multipartite Signaling Proteins and Uses Thereof
Multipartite Signaling Proteins and Uses Thereof
Multipartite Signaling Proteins and Uses Thereof
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Bcma Chimeric Antigen Receptors
Cblb Endonuclease Variants, Compositions, and Methods of Use
Cblb Endonuclease Variants, Compositions, and Methods of Use
Genome Edited Immune Effector Cells
Application:
16/083,727 →
Publication:
US 2019/0241910
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 30, 2013
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER; CERTO, MICHAEL
To: PREGENEN INC.
Reel/Frame 031513/0332 →
Assignment of Assignor's Interest
Apr 1, 2014
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER; CERTO, MICHAEL
To: PREGENEN INC.
Reel/Frame 032573/0895 →
Assignment of Assignor's Interest
Jul 22, 2014
From: PRECISION GENOME ENGINEERING, INC.
To: BLUEBIRD BIO, INC.
Reel/Frame 033366/0768 →
Assignment of Assignor's Interest
Jul 22, 2014
From: PRECISION GENOME ENGINEERING, INC.
To: BLUEBIRD BIO, INC.
Reel/Frame 033366/0764 →
Assignment of Assignor's Interest
Jul 24, 2014
From: FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC
Reel/Frame 033388/0315 →
Assignment of Assignor's Interest
Jul 24, 2014
From: MORGAN, RICHARD; FRIEDMAN, KEVIN; MAIER, DAWN
To: BLUEBIRD BIO, INC.
Reel/Frame 033388/0322 →
Assignment of Assignor's Interest
Aug 25, 2014
From: MORGAN, RICHARD; RYU, BYOUNG; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 033605/0001 →
Assignment of Assignor's Interest
Dec 16, 2014
From: FRIEDMAN, KEVIN; MORGAN, RICHARD
To: BLUEBIRD BIO, INC.
Reel/Frame 034515/0035 →
Assignment of Assignor's Interest
Jul 14, 2015
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 036077/0910 →
Assignment of Assignor's Interest
Aug 31, 2015
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 036455/0987 →
Assignment of Assignor's Interest
Sep 1, 2015
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 036471/0650 →
Assignment of Assignor's Interest
Mar 25, 2016
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER
To: BLUEBIRD BIO, INC.
Reel/Frame 038101/0437 →
Assignment of Assignor's Interest
Jun 14, 2016
From: CERTO, MICHAEL T.; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 038908/0210 →
Assignment of Assignor's Interest
Apr 13, 2017
From: LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 042001/0027 →
Assignment of Assignor's Interest
Apr 27, 2017
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER
To: BLUEBIRD BIO, INC.
Reel/Frame 042163/0001 →
Assignment of Assignor's Interest
Dec 1, 2017
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 044278/0214 →
Assignment of Assignor's Interest
Mar 16, 2018
From: MORGAN, RICHARD; FRIEDMAN, KEVIN; MAIER, DAWN
To: BLUEBIRD BIO, INC.
Reel/Frame 045257/0775 →
Assignment of Assignor's Interest
Nov 6, 2018
From: FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 047424/0680 →
Assignment of Assignor's Interest
Feb 6, 2019
From: CERTO, MICHAEL T.; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 048251/0932 →
Assignment of Assignor's Interest
Jul 24, 2019
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 049850/0224 →
Assignment of Assignor's Interest
Nov 21, 2019
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER; CERTO, MICHAEL
To: BLUEBIRD BIO, INC.
Reel/Frame 051078/0142 →
Assignment of Assignor's Interest
Nov 25, 2019
From: JARJOUR, JORDAN; ASTRAKHAN, ALEXANDER; CERTO, MICHAEL
To: BLUEBIRD BIO, INC.
Reel/Frame 051105/0223 →
Assignment of Assignor's Interest
Dec 30, 2019
From: FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 051385/0617 →
Assignment of Assignor's Interest
Jul 14, 2020
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 053204/0339 →
Assignment of Assignor's Interest
Oct 26, 2020
From: MORGAN, RICHARD; FRIEDMAN, KEVIN
To: BLUEBIRD BIO, INC.
Reel/Frame 054165/0882 →